(Q36263395)

English

Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Labrie F

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Dupont A

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Bélanger A

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Emond J

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Monfette G

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

1 June 1984

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

number of pages

3

1 reference

based on heuristic

inferred from page(s)

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

81

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

12

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

3861-3863

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=345321

30 September 2017

Treatment of stage IV carcinoma of the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=345321

30 September 2017

Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=345321

29 June 2018

New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=345321

22 September 2018

Simultaneous radioimmunoassay of progestins, androgens and estrogens in rat testis

1 reference

https://pubmed.ncbi.nlm.nih.gov/6427777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/6427777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of metastatic prostatic cancer with a potent luteinizing hormone releasing hormone analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/6427777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.81.12.3861

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1984PNAS...81.3861L

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36263395&oldid=1856253913"